AVITA Medical Stock Price, News & Analysis (NASDAQ:RCEL) $10.85 +0.12 (+1.12%) (As of 11/27/2023 ET) Add Compare Share Share Today's Range$10.46▼$10.9850-Day Range$9.29▼$14.8752-Week Range$6.29▼$21.70Volume124,795 shsAverage Volume193,875 shsMarket Capitalization$277.22 millionP/E RatioN/ADividend YieldN/APrice Target$26.40 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media AVITA Medical MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside143.3% Upside$26.40 Price TargetShort InterestHealthy2.36% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.62Based on 3 Articles This WeekInsider TradingAcquiring Shares$25,030 Bought Last QuarterProj. Earnings GrowthGrowingFrom ($1.47) to ($1.10) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.33 out of 5 starsMedical Sector241st out of 936 stocksSurgical & Medical Instruments Industry29th out of 92 stocks 3.5 Analyst's Opinion Consensus RatingAVITA Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 5 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $26.40, AVITA Medical has a forecasted upside of 143.3% from its current price of $10.85.Amount of Analyst CoverageAVITA Medical has only been the subject of 2 research reports in the past 90 days. Previous Next 5.0 Short Interest Percentage of Shares Shorted2.36% of the float of AVITA Medical has been sold short.Short Interest Ratio / Days to CoverAVITA Medical has a short interest ratio ("days to cover") of 3.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in AVITA Medical has recently decreased by 20.31%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldAVITA Medical does not currently pay a dividend.Dividend GrowthAVITA Medical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for RCEL. Previous Next 2.6 News and Social Media Coverage News SentimentAVITA Medical has a news sentiment score of 0.62. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for AVITA Medical this week, compared to 1 article on an average week.MarketBeat Follows3 people have added AVITA Medical to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, AVITA Medical insiders have bought more of their company's stock than they have sold. Specifically, they have bought $25,030.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 2.05% of the stock of AVITA Medical is held by insiders.Percentage Held by InstitutionsOnly 29.88% of the stock of AVITA Medical is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for AVITA Medical are expected to grow in the coming year, from ($1.47) to ($1.10) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of AVITA Medical is -8.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of AVITA Medical is -8.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAVITA Medical has a P/B Ratio of 3.20. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About AVITA Medical Stock (NASDAQ:RCEL)AVITA Medical, Inc. operates as a regenerative medicine company in the United States, Australia, Japan, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's skin. Its lead product is RECELL System, a platform technology allows for the preparation and delivery of spray-on skin cells to regenerate natural healthy epidermis, as well as to use in the treatment of acute thermal burns in patients eighteen years and older. AVITA Medical, Inc. has a research agreement with the University of Colorado School of Medicine to establish pre-clinical proof-of-concept for a spray-on treatment of genetically corrected cells; and with Houston Methodist Research Institute to explore molecular reversal of cellular aging through a novel cell suspension delivery system. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.Read More RCEL Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart RCEL Stock News HeadlinesNovember 22, 2023 | americanbankingnews.comAVITA Medical (NASDAQ:RCEL) Receives "Overweight" Rating from Cantor FitzgeraldNovember 20, 2023 | msn.comAvita Medical cuts 2023 commercial revenue guidance on longer hospital approval timelinesNovember 28, 2023 | DTI Trader (Ad)Important info on NVDA tradeToday, I’m pulling back the curtain on my all-new Everyday Income project. A way for everyday folks to target a couple hundred bucks or more every single day the markets are open… Without breaking a sweat!November 11, 2023 | markets.businessinsider.comAvita Medical Surpasses Expectations: Exploring New Markets and International Expansion with Strong Financial BackingNovember 11, 2023 | markets.businessinsider.comAvita Medical’s Promising Financial Trajectory: A Buy Rating Based on Strong Growth Indicators and Diversifying Revenue StreamsNovember 9, 2023 | benzinga.comAVITA Medical: Q3 Earnings InsightsNovember 9, 2023 | finance.yahoo.comAVITA Medical Announces Distribution Partnership with PolyMedics Innovations to Expand to EuropeOctober 19, 2023 | finance.yahoo.comAVITA Medical to Announce Third Quarter 2023 Financial ResultsNovember 28, 2023 | DTI Trader (Ad)Important info on NVDA tradeToday, I’m pulling back the curtain on my all-new Everyday Income project. A way for everyday folks to target a couple hundred bucks or more every single day the markets are open… Without breaking a sweat!October 18, 2023 | markets.businessinsider.comAvita Medical’s Steady Performance and Positive Future Prospects Prompt Buy Rating: An AnalysisOctober 18, 2023 | msn.comAvita Medical reports preliminary commercial revenue of $13.5MOctober 18, 2023 | finance.yahoo.comAVITA Medical Announces Preliminary Third Quarter 2023 Financial Highlights and Secures up to $90 million of Non-Dilutive Debt Financing with OrbiMed to Support Growth InitiativesSeptember 25, 2023 | finance.yahoo.comAVITA Medical Receives Best Product Award at the American Association for the Surgery of TraumaSeptember 22, 2023 | fool.comAvita Medical (ASX: AVH)September 21, 2023 | finance.yahoo.comAVITA Medical to Present at the Cantor Global Healthcare ConferenceSeptember 15, 2023 | finance.yahoo.comWith 49% stake, AVITA Medical, Inc. (ASX:AVH) seems to have captured institutional investors' interestSeptember 6, 2023 | finance.yahoo.comAVITA Medical to Participate in Upcoming Investor ConferencesAugust 27, 2023 | insidermonkey.com5 Best Cosmetic Surgery and Aesthetics Stocks to BuyAugust 23, 2023 | msn.comCantor Fitzgerald Reiterates AVITA Medical (RCEL) Overweight RecommendationAugust 22, 2023 | markets.businessinsider.comExpert Ratings for AVITA MedicalAugust 12, 2023 | finance.yahoo.comAVITA Medical, Inc. (NASDAQ:RCEL) Q2 2023 Earnings Call TranscriptAugust 12, 2023 | msn.comPiper Sandler Maintains AVITA Medical (RCEL) Overweight RecommendationAugust 11, 2023 | investing.comAvita Medical (RCEL) Earnings Dates & ReportsAugust 10, 2023 | finance.yahoo.comAVITA Medical Reports Second Quarter Financial ResultsAugust 2, 2023 | msn.comAVITA Medical (RCEL) Price Target Increased by 14.02% to 26.27July 28, 2023 | msn.comB of A Securities Maintains AVITA Medical (RCEL) Buy RecommendationJuly 20, 2023 | finance.yahoo.comAVITA Medical to Announce Second Quarter 2023 Financial ResultsSee More Headlines Receive RCEL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for AVITA Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/08/2021Today11/27/2023Fiscal Year End12/31/2023Next Earnings (Estimated)2/22/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:RCEL CUSIPN/A CIK1762303 Webwww.avitamedical.com Phone(833) 462-8482FaxN/AEmployees126Year Founded2008Price Target and Rating Average Stock Price Target$26.40 High Stock Price Target$40.00 Low Stock Price Target$19.00 Potential Upside/Downside+143.3%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)($1.33) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-26,670,000.00 Net Margins-74.16% Pretax Margin-73.98% Return on Equity-45.82% Return on Assets-37.60% Debt Debt-to-Equity RatioN/A Current Ratio6.25 Quick Ratio5.88 Sales & Book Value Annual Sales$34.42 million Price / Sales8.05 Cash FlowN/A Price / Cash FlowN/A Book Value$3.39 per share Price / Book3.20Miscellaneous Outstanding Shares25,550,000Free Float25,027,000Market Cap$277.22 million OptionableNot Optionable Beta1.54 Social Links 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesMr. James M. Corbett (Age 65)CEO, President & Executive Director Comp: $787.1kMr. Andrew Quick (Age 52)Chief Technology Officer Comp: $615.86kMs. Donna Shiroma (Age 61)General Counsel & Secretary Comp: $642.72kMr. David O'TooleChief Financial OfficerMr. David FencilSenior Vice President of Global OperationsMs. Jessica EkebergInvestor Relations ExecutiveMs. Debbie GarnerSenior Vice President of Global Marketing & StrategyMr. Rob HallSenior Vice President of Human ResourcesMr. Terry BromleySenior Vice President of Global SalesDr. Niraj Doshi J.D.P.M.P., Ph.D., Senior Vice President of Product Development & Program ManagementMore ExecutivesKey CompetitorsBioventusNYSE:BVS908 DevicesNASDAQ:MASSNano-X ImagingNASDAQ:NNOXClearPoint NeuroNASDAQ:CLPTApyx MedicalNASDAQ:APYXView All CompetitorsInsiders & InstitutionsDeutsche Bank AGBought 4,156 shares on 11/24/2023Ownership: 0.061%Walleye Capital LLCBought 50,500 shares on 11/21/2023Ownership: 0.198%David D O'tooleBought 1,000 shares on 11/16/2023Total: $12,150.00 ($12.15/share)Sei Investments Co.Bought 21,084 shares on 11/15/2023Ownership: 0.083%AQR Capital Management LLCBought 10,242 shares on 11/15/2023Ownership: 0.040%View All Insider TransactionsView All Institutional Transactions RCEL Stock Analysis - Frequently Asked Questions Should I buy or sell AVITA Medical stock right now? 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AVITA Medical in the last year. There are currently 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" RCEL shares. View RCEL analyst ratings or view top-rated stocks. What is AVITA Medical's stock price target for 2024? 5 Wall Street analysts have issued twelve-month price objectives for AVITA Medical's stock. Their RCEL share price targets range from $19.00 to $40.00. On average, they predict the company's stock price to reach $26.40 in the next year. This suggests a possible upside of 143.3% from the stock's current price. View analysts price targets for RCEL or view top-rated stocks among Wall Street analysts. How have RCEL shares performed in 2023? AVITA Medical's stock was trading at $6.60 at the beginning of the year. Since then, RCEL shares have increased by 64.4% and is now trading at $10.85. View the best growth stocks for 2023 here. When is AVITA Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, February 22nd 2024. View our RCEL earnings forecast. How were AVITA Medical's earnings last quarter? AVITA Medical, Inc. (NASDAQ:RCEL) announced its earnings results on Monday, November, 8th. The company reported ($0.24) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.40) by $0.16. The firm had revenue of $7.02 million for the quarter, compared to the consensus estimate of $6.98 million. AVITA Medical had a negative trailing twelve-month return on equity of 45.82% and a negative net margin of 74.16%. During the same quarter in the previous year, the firm earned ($0.48) earnings per share. What guidance has AVITA Medical issued on next quarter's earnings? AVITA Medical issued an update on its FY 2023 earnings guidance on Wednesday, October, 18th. The company provided EPS guidance of for the period. The company issued revenue guidance of $51.00 million-$53.00 million, compared to the consensus revenue estimate of $52.41 million. What other stocks do shareholders of AVITA Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other AVITA Medical investors own include NVIDIA (NVDA), Block (SQ), Alibaba Group (BABA), Micron Technology (MU), Netflix (NFLX), PayPal (PYPL), Twilio (TWLO), AbbVie (ABBV), Inovio Pharmaceuticals (INO) and Livongo Health (LVGO). Who are AVITA Medical's major shareholders? AVITA Medical's stock is owned by a number of institutional and retail investors. Top institutional shareholders include EAM Investors LLC (0.98%), Bank of New York Mellon Corp (0.50%), Charles Schwab Investment Management Inc. (0.27%), Assenagon Asset Management S.A. (0.26%), Walleye Capital LLC (0.20%) and Invesco Ltd. (0.13%). Insiders that own company stock include David D O'toole, Donna Shiroma, Michael S Perry, Michael S Perry and Suzanne Crowe. View institutional ownership trends. How do I buy shares of AVITA Medical? Shares of RCEL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (NASDAQ:RCEL) was last updated on 11/28/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AVITA Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.